Post Discharge Trial to Enhance Immunity in Severely Malnourished Children
Enhancing Immunity and Nutrition in Severely Malnourished Children Following Hospital Discharge: a Two Arm Open-label Randomized Controlled Trial of Microbiota-Directed Food vs. Zinc With Micronutrient Powder and Khichuri
1 other identifier
interventional
150
0 countries
N/A
Brief Summary
The goal of this study is to evaluate the efficacy of microbiota-directed food in comparison to zinc with micronutrient powder and Khichuri on changes in circulating immune cells (monocytes, T cells, B cells, and NK cells) in malnourished children after recovery from acute infection. The study aims to answer the research question: Does microbiota-directed food (MDF) compared to zinc with micronutrient powder (MNP) and Khichuri therapy enhance immunity in children with severe acute malnutrition? The researcher will compare the effectiveness of microbiota-directed food (MDF) versus zinc with micronutrient powder (MNP) and Khichuri therapy to see if MDF enhances immunity in severely malnourished children. Severely malnourished children will:
- Receive microbiota-directed food (MDF) or zinc with micronutrient powder (MNP) and Khichuri every day for 12 weeks.
- Phenotyping of circulating immune cells (NK cells, T cells, B cells) will be conducted using flow cytometry and fluorescence-activated cell sorting techniques.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 28, 2024
CompletedFirst Posted
Study publicly available on registry
July 31, 2024
CompletedStudy Start
First participant enrolled
August 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedAugust 2, 2024
June 1, 2024
1.4 years
July 28, 2024
July 31, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
NK cells
Differences in the proportion and activity of circulating NK cells between the groups 12 weeks after the intervention, measured by flow cytometry/fluorescence-assisted cell sorter (FACS).
12 weeks
Secondary Outcomes (8)
Circulating immune cells
12 weeks
Cytokines and chemokines
12 weeks
Micro biocidal capacity
12 weeks
Rate of weight gain
12 weeks
Diarrhea and pneumonia
12 weeks
- +3 more secondary outcomes
Study Arms (2)
Microbiota-directed food
EXPERIMENTALChildren randomized to this group will receive Microbiota-directed food (MDF) daily for 12 weeks. MDF can modulate the gut microbiota and enhance host immunity, growth, and development in malnourished children.
Khichuri
ACTIVE COMPARATORChildren randomized to this group will receive zinc with Micronutrient powder (MNP) and Khichuri daily for 12 weeks.
Interventions
MDF can modulate the gut microbiota and enhance host immunity, growth, and development in malnourished children. Each sachet of MDF (100 gm) provides approximately 500 kcal.
Khichuri is a home-based nutritious food with high energy and protein. This arm also contains zinc (10 gm/day), micronutrient powder, and an egg daily.
Eligibility Criteria
You may qualify if:
- Children aged 6 months to 36 months, and
- Severe acute malnutrition as evident by weight-for-length z-score (WLZ) \< -3 and or mid-upper arm circumference (MUAC) \< 11.5 cm, and or edema of both feet, and
- Completed the acute phase management for SAM and stayed at NRU for 7±4 days, with no medical complications, e.g. lethargic/unconscious, convulsions, unable to drink, persistent vomiting, respiratory distress.
- Residing within the Dhaka district.
- Parents/guardians provided written informed consent.
You may not qualify if:
- WLZ ≥ -3 or MUAC ≥11.5 cm.
- Presence of lethargy/unconsciousness, convulsions, unable to drink, persistent vomiting, respiratory distress.
- Participants who receive multiple courses of antibiotic (\>2 courses during acute phase) treatment for a prolonged period (\>14 days).
- Persistent diarrhea (≥14 days).
- Chronic illness or disability affecting food intake, e.g. TB, HIV, congenital defects, cerebral palsy
- Treated for SAM in the previous 3 months.
- Known case of soy, peanut, or milk protein allergy.
- Any sibling of the enrolled child.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Farzana Afroze
International Centre for Diarrhoeal Disease Research, Bangladesh
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 28, 2024
First Posted
July 31, 2024
Study Start
August 1, 2024
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
August 2, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share